III. Mechanism

  1. Blocks Dipeptidyl Peptidase-4 Inhibitor (DPP-4) allowing 2-3x accumulation of GLP-1
  2. Reduce Incretin degradation
  3. Differs from Byetta: Weight neutral, no Nausea

IV. Precautions

  1. Gliptins are less than half as effective as lower cost medications (e.g. Metformin, Sulfonylureas)
  2. No longterm evidence of improved outcomes
  3. Expensive (>$400/month)
  4. Decrease dose in renal Impairment
  5. May consider for those close to goal AND
    1. Already either on other Oral Hypoglycemics or in whom they are contraindicated (e.g. Chronic Kidney Disease)

V. Contraindications

  1. Type I Diabetes Mellitus
  2. Prior history of malignancy
    1. Due to increased risk of cancer invasion and metastases
  3. Women of child bearing age (relative contraindication)
    1. Teratogenicity risk
  4. Congestive Heart Failure

VI. Adverse Effects

  1. Acute Pancreatitis
    1. Incidence may be as high as 1 in 50 for two years
    2. Singh (2013) JAMA Intern Med 173(7):534-9 [PubMed]
  2. Serious Allergic Reaction (Sitagliptin)
    1. Anaphylaxis
    2. Angioedema
  3. Hepatotoxicity (Vildagliptin)
  4. Congestive Heart Failure exacerbation
    1. Risk of hospitalized CHF exacerbation: 1 in 150 patients/2 years using Saxigliptin or Alogliptin
    2. Sitagliptin (Januvia) is less associated with CHF exacerbation
    3. Scirica (2013) N Engl J Med 369(14):1317-26 [PubMed]
  5. Severe, persistent Joint Pain (rare)
    1. Stop agent if suspect Gliptin-induced pain (and avoid other Gliptins)
    2. Consider other possible causes (e.g. Statin induced Myopathy)
    3. FDA Alert
      1. http://www.fda.gov/drugs/drugsafety/ucm459579.htm

VII. Preparations

  1. Sitagliptin (Januvia)
    1. May be dosed with or without food
    2. Fewer Drug Interactions than Saxagliptin (Onglyza) and Linagliptin (Tradjenta)
    3. Standard dosing
      1. Creatinine Clearance >50 ml/min: 100 mg once daily
    4. Renal Insufficiency
      1. Consider Tradjenta instead, as does not require Renal Dosing adjustment
      2. Creatinine Clearance 30-49 ml/min: 50 mg once daily
      3. Creatinine Clearance <30 ml/min: 25 mg once daily
  2. Saxagliptin (Onglyza)
    1. Significant CYP3A4 Drug Interactions
    2. Adjust for renal Impairment
    3. CHF risk
  3. Linagliptin (Tradjenta)
    1. Significant CYP3A4 inducer and P-Glycoprotein Inducer
    2. No Renal Dosing required
  4. Alogliptin (Nesina)
    1. Fewer Drug Interactions than Saxagliptin (Onglyza) and Linagliptin (Tradjenta)
    2. Adjust for renal Impairment
    3. CHF risk
    4. First Gliptin to be generic as of 2016

VIII. Preparations: Combination

  1. Kanzano (Alogliptin and Metformin)
  2. Oseni (Alogliptin and Pioglitazone)
  3. Janumet (Stagliptin and Metformin)
  4. Trijardy XR (Linagliptin, Empagliflozin and Metformin XR)

Images: Related links to external sites (from Bing)

Related Studies

Cost: Medications

januvia (on 1/6/2022 at Medicaid.Gov Survey of pharmacy drug pricing)
JANUVIA 100 MG TABLET $16.68 each
JANUVIA 25 MG TABLET $16.66 each
JANUVIA 50 MG TABLET $16.69 each
saxagliptin (on 10/18/2023 at Medicaid.Gov Survey of pharmacy drug pricing)
SAXAGLIPTIN HCL 5 MG TABLET Generic $1.63 each
onglyza (on 1/1/2022 at Medicaid.Gov Survey of pharmacy drug pricing)
ONGLYZA 2.5 MG TABLET $15.07 each
ONGLYZA 5 MG TABLET $15.07 each
tradjenta (on 1/1/2023 at Medicaid.Gov Survey of pharmacy drug pricing)
TRADJENTA 5 MG TABLET $16.80 each
alogliptin (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing)
ALOGLIPTIN 12.5 MG TABLET Generic $5.17 each
ALOGLIPTIN 25 MG TABLET Generic $5.30 each
ALOGLIPTIN 6.25 MG TABLET Generic $5.22 each
ALOGLIPTIN-METFORMIN 12.5-1000 Generic $2.55 each
ALOGLIPTIN-METFORMIN 12.5-500 Generic $2.44 each
nesina (on 3/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing)
NESINA 25 MG TABLET Generic $5.30 each